Literature DB >> 33348456

Nocturia and electrocardiographic abnormalities among patients at an inner-city cardiology clinic.

Pakinam Mekki1, Thomas F Monaghan2, Lily Lee1, Christina W Agudelo2, Fred Gong2, Christopher D George1, Kyle P Michelson2, Zhan D Wu2, Jeffrey P Weiss2, Karel Everaert3, Roger R Dmochowski4, Donald L Bliwise5, Alan J Wein6, Jason M Lazar1.   

Abstract

AIMS: Nocturia has been increasingly recognized as a potential manifestation of cardiovascular disease. However, the relationship between nocturia and electrocardiographic (ECG) abnormalities has not been studied. This study aims to characterize the diagnostic utility of nocturia in identifying left ventricular hypertrophy (LVH), left atrial enlargement (LAE), and prolonged QTc on ECG.
METHODS: Retrospective analysis of nocturnal voiding frequency and contemporaneous ECG data from consecutive patients evaluated at a university-based outpatient cardiology clinic. Three sets of three incremental binary multiple logistic regression models controlling for (1) age, (2) sex and race, and (3) body mass index, hypertension, diabetes mellitus, and diuretic utilization were performed to determine whether nocturia was predictive of LVH, LAE, and prolonged QTc.
RESULTS: Included patients (n = 143, 77.6% nocturia) were predominantly African-American (89.5%), female (74.1%), and obese (61.5%), of whom 44.1%, 41.3%, and 27.3% had LVH, LAE, and prolonged QTc, respectively. Older age, African-American race, obesity, hypertension, diuretic use, LVH, and LAE were significantly associated with nocturia on univariate analysis. No significant differences were observed in the strength of associations between nocturia and LVH, LAE, or QTc prolongation based on age. Nocturia independently predicted LVH in Models I-III (odds ratios [ORs], 2.99-3.20; relative risks [RRs], 1.18 for all, p ≤ .046) and LAE in Models I-III (ORs, 4.24-4.72; RRs, 1.21 for all, p ≤ .015). No significant associations were observed between nocturia and prolonged QTc.
CONCLUSIONS: Nocturia may be a risk marker for underlying structural cardiac abnormalities.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  LUTS; biomarker; hypertension; left atrial enlargement; left ventricular hypertrophy; urology

Mesh:

Year:  2020        PMID: 33348456     DOI: 10.1002/nau.24590

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  2 in total

1.  Nocturia independently predicts left ventricular hypertrophy and left atrial enlargement among patients with cardiac symptoms.

Authors:  Kuo-Wei Kao; Weiming Cheng; Ching-Ju Wu; Yu-Hua Fan
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

2.  The association between diabetes and nocturia: A systematic review and meta-analysis.

Authors:  Zhiwei Fu; Fang Wang; Xing Dang; Tao Zhou
Journal:  Front Public Health       Date:  2022-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.